0.7344
Medicus Pharma Ltd (MDCX) 最新ニュース
Medicus Pharma reports positive phase 2 results for microneedle skin cancer treatment - Proactive financial news
MDCX Navigates Uncertain Waters Amid Recent Earnings and Market Trends - timothysykes.com
Medicus Pharma Stock Swings After Skin Cancer Treatment Results - Benzinga
Medicus Pharma reports positive Phase 2 results for microneedle treatment for basal cell carcinoma - Yahoo Finance
Medicus Pharma Posts Strong Phase 2 Data for Microneedle Basal Cell Carcinoma Therapy - TipRanks
Medicus Pharma Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance and 40% Histological Clearance (CR) at Day 57 in 200μg Cohort - Bitget
Microneedle skin cancer patch shows 73% clearance in Medicus trial - Stock Titan
Medicus Pharma on Bloomberg World - Bluffton Today
New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM - ACCESS Newswire
Medicus Pharma Showcases SkinJect and Teverelix Strategy at Roth Conference - TipRanks
Medicus Pharma to present at Roth Conference - Proactive financial news
Medicus Pharma To Participate in the 38th Annual Roth Conference - The Manila Times
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform - Treasure Coast News
Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - Press & Sun-Bulletin
MDCX PE Ratio & Valuation, Is MDCX Overvalued - Intellectia AI
Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) - Montgomery Advertiser
MDCX Technical Analysis & Stock Price Forecast - Intellectia AI
MDCX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Reliant AI – Weekly Recap - TipRanks
Can Medicus Pharma Ltd. sustain its profitabilityRate Hike & High Win Rate Trade Alerts - mfd.ru
Aug Technicals: Why is Medicus Pharma Ltd stock going downQuarterly Market Review & AI Forecasted Stock Moves - baoquankhu1.vn
Market Outlook: How is Redwood Trust Inc managing supply chain issuesQuarterly Trade Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Medicus Pharma receives FDA clearance to begin Phase 2b Teverelix study - MSN
Reliant AI Partnership Targets Faster, More Efficient Clinical Trials - TipRanks
Reliant AI Partnership Targets Faster, More Efficient Clinical Trials With Medicus Pharma - TipRanks
Medicus Pharma Receives FDA Clearance to Begin Phase 2b Teverelix Study - MyChesCo
Is Medicus Pharma Ltd. Equity Warrant vulnerable to short sellersShare Buyback & Stepwise Trade Execution Plans - mfd.ru
Does Medicus Pharma Ltd. Equity Warrant have declining or rising EPS2025 Support & Resistance & Fast Entry High Yield Stock Tips - mfd.ru
Medicus Pharma’s Teverelix Phase 2b trial cleared by FDAICYMI - Proactive financial news
Can Medicus Pharma Ltd. Equity Warrant ride the EV waveWeekly Market Outlook & Short-Term High Return Ideas - mfd.ru
Aug Reactions: Is Medicus Pharma Ltd Equity Warrant subject to activist investor interestEarnings Performance Report & High Win Rate Trade Tips - baoquankhu1.vn
Is Medicus Pharma Ltd. Equity Warrant a speculative investmentGold Moves & Low Volatility Stock Suggestions - mfd.ru
Will Medicus Pharma Ltd. Equity Warrant benefit from rising consumer demand2025 Top Decliners & Comprehensive Market Scan Insights - mfd.ru
Why Medicus Pharma Ltd. stock attracts high net worth investorsDollar Strength & High Win Rate Trade Alerts - mfd.ru
Aug Decliners: Is Medicus Pharma Ltd Equity Warrant likely to announce a buybackMarket Trend Review & Short-Term High Return Strategies - baoquankhu1.vn
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement - Asbury Park Press
大文字化:
|
ボリューム (24 時間):